Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Investment Group Just Paid $605 Million for This Bay Area Pharma June 7, 2017 Cash-Strapped Alder Biopharma Secures $160 Million in Stock Sale to Continue Operations July 13, 2017 Takeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device November 6, 2017
Cash-Strapped Alder Biopharma Secures $160 Million in Stock Sale to Continue Operations July 13, 2017
Takeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device November 6, 2017
